William D. Waddill sold $1.1M of Protagonist Therapeutics (PTGX)

Executed Jun 23, disclosed Jun 25, 2 days later.

Value, as filed

$1.1M

9,000 sh × $117.94

Executed

Jun 23

the trade date, as filed

Disclosed

Jun 25

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

William D. Waddill Director profile →

William D. Waddill (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $1.7M of PTGX (20,000 sh × $83.68, as filed), executed Feb 6.

The name

PTGX

Protagonist Therapeutics, Inc. PTGX · Healthcare · 36 filings in 24 months ticker →

Healthcare · Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by William D. Waddill in PTGX

PTGXSALE Protagonist Therapeutics, Inc. $969K
9,000 sh × $107.68
Exec Jun 10
Filed Jun 11 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $897K
9,000 sh × $99.64
Exec May 29
Filed Jun 1 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $1.7M
20,000 sh × $83.68
Exec Feb 6
Filed Feb 6 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $979K
12,000 sh across 2 lots
Exec Oct 10 2025
Filed Oct 14 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $257K
4,000 sh × $64.25
Exec Sep 22 2025
Filed Sep 24 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $237K
4,000 sh × $59.25
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $217K
4,000 sh × $54.25
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $360K
8,000 sh × $45.00
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET